Turmeric and herb combo may boost ulcerative colitis treatment

NCT ID NCT07240168

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether adding CurQD, a mix of curcumin and QingDai, helps people with active ulcerative colitis who are already taking vedolizumab. Researchers will review records from 400 patients to see if the supplement helps them stay on vedolizumab longer and improves symptoms and biomarkers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CurQD (curcumin and QingDai combination)

What this could lead to

If it works, adding CurQD could help people with ulcerative colitis control their disease better and stay on vedolizumab longer.

What could go wrong

This is a retrospective study using existing records, not a controlled experiment. Results may be influenced by other factors, and the supplement's benefits are not proven yet.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Evinature

    Binyamina, Israel